Landscapes / Companies
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials
Trials
4 active
5 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Hypoxia-inducible factor inhibitor |
Merck & Co. |
Approved | 26 Feb 2027Phase 2 trial completes | ||
| Next date | 26 Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Kidney Cancer, ccRCC and 27 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | ccRCC, RCC and 3 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021